Skip to main content
    N

    Novo Nordisk A/S (NVO)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - GENERAL • NYSE

    $40.70
    -0.89 (-2.15%)

    Market Cap: $183.52B

    Last updated: Nov 17, 2026 at 5:28 PM ET

    Novo Nordisk A/S (NVO) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Novo Nordisk A/S (NVO) has a market cap of $183.52B. Its dividend yield is 4.41%. Its return on invested capital of 34.13% compares with a 12.84% median across 11 similar companies.

    Total Valuation

    Market Cap$183.52B
    Latest price (Nov 17, 2026)$40.70

    Key Dates

    The last ex-dividend date was Aug 17, 2026.

    Last Earnings DateNov 4, 2026
    Last Ex-Dividend DateAug 17, 2026
    Last Payment DateAug 25, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count fell 0.43% in the quarter ended Sep 30, 2026 and shrank 0.49% a year over 2 years.

    Shares Outstanding4.42B
    Shares Change (YoY)-0.67%
    Shares Change (QoQ)-0.43%
    Share Count Growth (2Y CAGR)-0.49%

    Valuation Ratios

    Sales and book value multiples are 3.5x and 5.4x. Its year-end P/S ranged from 4.7x to 13.8x from 2016 to 2025.

    P/S Ratio3.5x
    P/B Ratio5.4x
    P/TBV Ratio11.2x
    P/FCF Ratio26.0x

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 6.8x EBITDA and 28.0x free cash flow.

    EV / EBITDA6.8x
    EV / FCF28.0x

    Price Statistics

    The stock is down 12.75% over 52 weeks and trades 2.01% above its 50-day average.

    Beta (1Y)0.95
    52-Week Change-12.75%
    1-Month Change+5.95%
    3-Month Change-12.42%
    6-Month Change-6.89%
    5-Year Change-27.36%
    10-Year Change+125.10%
    Total Return (1Y)-8.89%
    Total Return (3Y CAGR)-24.45%
    Total Return (5Y CAGR)-4.82%
    Return vs SPY (1Y)-23.00%
    Max Drawdown (1Y)-44.39%
    Max Drawdown (3Y)-75.03%
    Sharpe Ratio (1Y)-0.26
    Correlation with SPY (1Y)0.28
    50-Day Average$39.90
    200-Day Average$42.46
    52-Week Range$34.15 to $61.11
    RSI (14 Days)52.1
    Average Volume (20 Days)12.27M

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 0.84x current liabilities, and total debt is 0.62x shareholder equity.

    Current Ratio0.84x
    Quick Ratio0.64x
    Debt / Equity0.62x
    Debt / EBITDA0.72x
    Interest Coverage10.13x

    Returns and Efficiency

    Return on invested capital is 34.13% over the last 12 months, against a 5-year average of 46.41%.

    Return on Equity (ROE)52.96%
    Return on Assets (ROA)19.25%
    Return on Invested Capital (ROIC)34.13%
    Return on Capital Employed (ROCE)43.12%
    ROE (5Y Average)67.14%
    ROA (5Y Average)22.95%
    ROIC (5Y Average)46.41%
    Asset Turnover0.60x
    Inventory Turnover1.26x
    Receivables Turnover3.26x
    Cash Conversion Cycle-79 days

    Taxes

    Income tax took 21.77% of pretax income over the last 12 months.

    Income Tax (TTM)DKK 31.49B
    Effective Tax Rate21.77%

    Scores

    NVO has an Altman Z-Score of 3.72, in the safe zone above 2.99, and a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.

    Altman Z-Score3.72
    Altman Z ZoneSafe
    Piotroski F-Score5 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of DKK 333.65B over the last 12 months is up 5.72% from the 12 months before.

    RevenueDKK 333.65B
    Revenue Growth (YoY)+5.72%
    Gross ProfitDKK 269.57B
    Operating IncomeDKK 141.43B
    Pretax IncomeDKK 144.67B
    Net IncomeDKK 113.18B
    EBITDADKK 184.57B
    EBITDKK 150.80B

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 36.35% of the DKK 599.16B in total assets.

    Working CapitalDKK -38.68B
    Shareholder EquityDKK 217.80B
    Tangible Book ValueDKK 106.03B
    Total AssetsDKK 599.16B
    Total LiabilitiesDKK 381.36B

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After DKK 81.82B of capital spending, operating cash flow left DKK 46.32B of free cash flow.

    Operating Cash FlowDKK 128.15B
    Capital ExpendituresDKK 81.82B
    Free Cash FlowDKK 46.32B
    Depreciation and AmortizationDKK 33.77B
    Dividends PaidDKK 52.02B

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 42.39%, against a 5-year average of 42.72%.

    Gross Margin80.79%
    Operating Margin42.39%
    Pretax Margin43.36%
    Net Margin33.92%
    EBITDA Margin55.32%
    EBIT Margin45.20%
    FCF Margin13.88%
    Gross Margin (5Y Average)83.47%
    Operating Margin (5Y Average)42.72%
    Net Margin (5Y Average)33.85%

    Growth

    Revenue grew 20.43% a year over 3 years.

    Revenue Growth (3Y CAGR)+20.43%
    Revenue Growth (5Y CAGR)+19.48%
    FCF Growth (3Y CAGR)-23.26%
    FCF Growth (5Y CAGR)-0.60%
    Operating Income Growth (3Y CAGR)+19.50%

    Revenue and profit by year

    Dividends and Yields

    NVO pays out 40.47% of earnings as dividends.

    Dividend Per Share (Annual)$1.80
    Dividend Yield4.41%
    Payment ScheduleSemi-Annual
    Dividend Growth (3Y CAGR)+29.23%
    Dividend Growth (5Y CAGR)+21.57%
    Payout Ratio40.47%
    FCF Payout Ratio115.78%
    FCF Yield3.84%

    Full dividend history

    Stock Splits

    The last split was a 2-for-1 forward split on Sep 20, 2023.

    Last Split DateSep 20, 2023
    Split TypeForward split
    Split Ratio2:1

    Peer Position

    Against 12 similar companies, NVO has the 9th highest P/S and the 3rd highest dividend yield.

    P/S Ratio3.5x vs 4.9x median
    ROIC34.13% vs 12.84% median
    Revenue Growth (Trailing 4 Quarters, YoY)+5.72% vs +5.71% median
    Dividend Yield4.41% vs 2.37% median

    Competitors compared

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About NVO

    What is NVO's market cap?

    Novo Nordisk A/S has a market cap of $183.52B.

    How many shares of NVO are outstanding?

    Novo Nordisk A/S has 4.42B shares outstanding. The count is down 0.67% from a year earlier.

    Does NVO pay a dividend?

    Yes. Novo Nordisk A/S pays $1.80 a share a year, a dividend yield of 4.41%.